Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives

European Journal of Pharmacology

Volumn 337, Issue 1, 1997, Pages 55-61

  Kosonen, Outi ^a   Kankaanranta, Hannu ^a   Vuorinen, Pauli ^a,b   Moilanen, Eeva ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

cGMP; Lymphocyte; Nitric oxide (NO); Nitric oxide (NO) releasing compound

Indexed keywords

3 (3 CHLORO 2 METHYLPHENYL) 5 (4 METHYLBENZENESULFONYLIMINO) 1,2,3,4 OXATRIAZOLE; 3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; CONCANAVALIN A; CYCLIC GMP; NITRIC OXIDE; OXATRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL;

CELL DIVISION; CELL SEPARATION; CONCANAVALIN A; CYCLIC GMP; ERYTHROCYTES; HUMANS; LYMPHOCYTES; NITRIC OXIDE; PENICILLAMINE; PLATELET AGGREGATION INHIBITORS; S-NITROSO-N-ACETYLPENICILLAMINE; TRIAZOLES;

EID: 0030777922     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01266-1     Document Type: Article

References (41)

1. Ahmann G.B., Sachs D.H., Hodes R.J. Requirement for an Ia-bearing accessory cell in Con A-induced T-cell proliferation. J. Immunol. 121:1978;1981-1989.
2. Albina J.E., Abate J.A., Henry W.L. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T-cell proliferation: Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:1991;144-148.
3. Axelsson K.L., Bornefeldt K.E., Norlander B., Wikberg J.E.S. Attomole sensitive radioimmunoassay for cyclic GMP. Second Messengers Phosphoproteins. 12:1988;145-154.
4. Barnes P.J., Liew F.Y. Nitric oxide and asthmatic inflammation. Immunol. Today. 16:1995;128-130.
5. Bukrinsky M.I., Nottet H.S.L.M., Schmidtmayerova H., Dubrovsky L., Flanagan C.R., Mullins M.E., Lipton S.A., Gendelman H.E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J. Exp. Med. 181:1995;735-745.
6. Corell T., Pedersen S.B., Lissau B., Moilanen E., Metsä-Ketelä T., Kankaanranta H., Vuorinen P., Vapaatalo H., Rydell E., Andersson R., Marcinkiewicz E., Korbut R., Gryglewski R. Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol. J. Pharmacol. 46:1994;553-566.
7. De Maria R., Cifone M.G., Trotta R., Rippo M.R., Festuccia C., Santoni A., Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 180:1994;1999-2004.
8. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leuk. Biol. 49:1991;380-387.
9. Feelisch M. Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur. Heart. J. 14 (Suppl. 1):1993;123-132.
10. Hoffman R.A., Langrehr J.M., Billiar T.R., Curran R.D., Simmons R.L. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J. Immunol. 145:1990;2220-2226.
11. Ignarro L.J. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41:1991;485-490.
12. Järvinen T.A.H., Moilanen T., Järvinen T.L.N., Moilanen E. Nitric oxide mediates interleukin-1-induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Med. Inflamm. 4:1995;107-111.
13. Kankaanranta H., Rydell E., Petersson A.S., Holm P., Moilanen E., Corell T., Karup G., Vuorinen P., Pedersen S.B., Wennmalm Å., Metsä-Ketelä T. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br. J. Pharmacol. 117:1996;401-406.
14. Karup G., Preikschat H., Wilhelmsen E.S., Pedersen S.B., Marcinkiewicz E., Cieslik K., Gryglewski R.J. Mesoionic oxatriazole derivatives: A new group of NO-donors. Pol. J. Pharmacol. 46:1994;541-552.
15. Kwon N.S., Stuehr D.J., Nathan C.F. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174:1991;761-767.
16. Lander H.M., Sehajpal P.K., Levine D.M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1993;1509-1516.
17. Lander H.M., Sehajpal P.K., Novogrodsky A. Nitric oxide signalling: A possible role for G proteins. J. Immunol. 151:1993;7182-7187.
18. ras. J. Biol. Chem. 270:1995;7017-7020.
19. Lejeune P., Lagadec P., Onier N., Pinard D., Ohshima H., Jeannin J.F. Nitric oxide involvement in tumor-induced immunosuppression. J. Immunol. 152:1994;5077-5083.
20. Lepoivre M., Chenais B., Yapo A., Lemaire G., Thelander L., Tenu J.P. Alteration of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J. Biol. Chem. 265:1990;14143-14149.
21. Malo-Ranta U., Ylä-Herttuala S., Metsä-Ketelä T., Jaakkola O., Moilanen E., Vuorinen P., Nikkari T. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett. 337:1994;179-183.
22. Mannick J.B., Asano K., Izumi K., Kieff E., Stamler J.S. Nitric oxide produced by human B-lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
23. Merryman P.F., Clancy R.M., He X.Y., Abramson S.B. Modulation of human T-cell responses by nitric oxide and its derivative, S-nitrosoglutathione. Arthritis Rheum. 36:1993;1414-1422.
24. Mills C.D. Molecular basis of 'suppressor' macrophages: Arginine metabolism via the nitric oxide synthase pathway. J. Immunol. 146:1991;2719-2723.
25. Moilanen E., Vapaatalo H. Nitric oxide in inflammation and immune response. Ann. Med. 27:1995;359-367.
26. Moilanen E., Vuorinen P., Kankaanranta H., Metsä-Ketelä T., Vapaatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol. 109:1993;852-858.
27. Moilanen, E., Arola, O., Malo-Ranta, U., Ylä-Herttuala, S., Vuorinen, P., Metsä-Ketelä, T., Vapaatalo, H., 1994. Nitric oxide donors inhibit neutrophil adhesion to endothelial cells. In: Moncada, S., Feelisch, M., Busse, R., Higgs, E.A. (Eds.), The Biology of Nitric Oxide, vol. 4. Portland Press, London, pp. 271-275.
28. Moilanen E., Moilanen T., Knowles R., Charles I., Kadoya Y., Al-Saffar N., Revell P.A., Moncada S. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am. J. Pathol. 150:1997;881-887.
29. Moncada S. The L-arginine: Nitric oxide pathway. Acta Physiol. Scand. 145:1992;201-227.
30. Moncada S., Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1995;1319-1330.
31. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-141.
32. Mossalayi M.D., Paul-Eugene N., Ouaaz F., Arock M., Kolb J.P., Kilchherr E., Debre P., Dugas B. Involvement of Fc epsilon RII/CD23 and L-arginine-dependent pathway in IgE-mediated stimulation of human monocyte functions. Int. Immunol. 6:1994;931-934.
33. Murphy M.E., Noack E. Nitric oxide assay using hemoglobin method. Methods Enzymol. 233:1994;240-250.
34. Schleifer K.W., Mansfield J.M. Suppressor macrophages in African trypanosomiasis inhibit T-cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151:1993;5492-5503.
35. Sicher S.C., Vazquez M.A., Lu C.Y. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1994;1293-1300.
36. Stamler J.S., Toone E.J., Lipton S.A., Sucher N.J. S(NO) signals: Translocation, regulation and a consensus motif. Neuron. 18:1997;691-696.
37. Sternberg J., McGuigan F. Nitric oxide mediates suppression of T-cell responses in murine Trypanosoma brucei infection. Eur. J. Immunol. 22:1992;2741-2744.
38. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., Mcsorley S.J., Garside P., Padron J., Philips R.S. Regulation of the immune response by nitric oxide differentially produced by T-helper type-1 and T-helper type-2 cells. Eur. J. Immunol. 24:1994;980-984.
39. Vilpo, J.A., Vilpo, L.M., Vuorinen, P., Moilanen, E., Metsä-Ketelä, T., 1994. Cytotoxicity of mesoionic oxatriazoles: a novel series of nitric oxide donors. In: Moncada, S., Feelisch, M., Busse, R., Higgs, E.A. (Eds.), The Biology of Nitric Oxide, vol. 4. Portland Press, London, pp. 286-291.
40. Virta M., Karp M., Vuorinen P. Nitric oxide donor-mediated killing of bioluminescent Escherichia coli. Antimicrob. Agents Chemother. 38:1994;2775-2779.
41. Vouldoukis I., Riveros-Moreno V., Dugas B., Ouaaz F., Becherel P., Debre P., Moncada S., Mossalayi M.D. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcεRII/CD23 surface antigen. Proc. Natl. Acad. Sci. USA. 92:1995;7804-7808.